DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 245 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $587,879 | +250.2% | 52,349 | +287.0% | 0.01% | +150.0% |
Q1 2024 | $167,870 | +108.5% | 13,527 | +134.9% | 0.00% | +300.0% |
Q4 2023 | $80,497 | -3.7% | 5,758 | +1.7% | 0.00% | -66.7% |
Q3 2023 | $83,598 | -39.4% | 5,660 | -47.0% | 0.00% | -40.0% |
Q2 2023 | $137,947 | +241912.3% | 10,677 | +83.8% | 0.01% | +150.0% |
Q1 2023 | $57 | -59.6% | 5,810 | -56.0% | 0.00% | -66.7% |
Q4 2022 | $141 | -99.9% | 13,204 | -10.4% | 0.01% | +200.0% |
Q3 2022 | $154,000 | -43.4% | 14,735 | -31.7% | 0.00% | -66.7% |
Q2 2022 | $272,000 | -25.1% | 21,582 | -35.6% | 0.01% | +100.0% |
Q1 2022 | $363,000 | -11.5% | 33,516 | +15.1% | 0.00% | -57.1% |
Q4 2021 | $410,000 | -60.8% | 29,109 | -46.5% | 0.01% | -74.1% |
Q3 2021 | $1,046,000 | +1415.9% | 54,443 | +676.3% | 0.03% | +1250.0% |
Q2 2021 | $69,000 | -68.6% | 7,013 | -68.6% | 0.00% | -50.0% |
Q1 2021 | $220,000 | +18.3% | 22,323 | -46.7% | 0.00% | -33.3% |
Q4 2020 | $186,000 | +26.5% | 41,920 | +23.5% | 0.01% | +200.0% |
Q3 2020 | $147,000 | -26.5% | 33,957 | +50.3% | 0.00% | -75.0% |
Q2 2020 | $200,000 | +952.6% | 22,593 | +568.4% | 0.01% | +300.0% |
Q4 2019 | $19,000 | +375.0% | 3,380 | +594.0% | 0.00% | – |
Q1 2019 | $4,000 | +100.0% | 487 | +235.9% | 0.00% | – |
Q3 2018 | $2,000 | -96.2% | 145 | -95.7% | 0.00% | -100.0% |
Q2 2018 | $52,000 | +160.0% | 3,411 | +225.2% | 0.00% | 0.0% |
Q4 2017 | $20,000 | -70.6% | 1,049 | -67.1% | 0.00% | -50.0% |
Q3 2017 | $68,000 | +240.0% | 3,187 | +53.4% | 0.01% | +200.0% |
Q2 2017 | $20,000 | +100.0% | 2,078 | +23.7% | 0.00% | +100.0% |
Q1 2017 | $10,000 | +233.3% | 1,680 | +140.0% | 0.00% | – |
Q4 2016 | $3,000 | -86.4% | 700 | -39.7% | 0.00% | -100.0% |
Q1 2016 | $22,000 | +266.7% | 1,161 | +362.5% | 0.00% | +200.0% |
Q4 2015 | $6,000 | +200.0% | 251 | +226.0% | 0.00% | – |
Q3 2015 | $2,000 | -94.6% | 77 | -95.1% | 0.00% | -100.0% |
Q2 2015 | $37,000 | -75.8% | 1,578 | -76.7% | 0.00% | -84.2% |
Q1 2015 | $153,000 | +628.6% | 6,787 | +436.5% | 0.02% | +850.0% |
Q4 2014 | $21,000 | – | 1,265 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
Maven Securities LTD | 264,989 | $931,000 | 0.29% |
Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |